ino-1001
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2004 (NCT00271765)
Timeline
Indications
Mechanism of action
- Poly [ADP-ribose] polymerase 4INHIBITOR
PARP4 inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
O=c1[nH]cnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O- Mol. weight
- 268.23 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1556 ↗
Also known as
- ino1001
- ino 1001
- ino-1001
- ino-1001
- ino-1001
- ino-1001
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00271167 | Phase 2 | Oct 1, 2005 | Inotek |
| NCT00272415 | Phase 1 | Oct 1, 2005 | Genentech |
| NCT00271765 | Phase 2 | Jan 1, 2004 | Inotek |
Showing 3 of 3 trials
Page 1 / 1